Viatris’ Once-Monthly Copaxone Filing Imminent, Botox ‘On Track’

Recent Approval For Revance Brand Encourages Viatris On Botox

 
• By Dean Rudge
  
multiple sclerosis
Viatris is looking to expand its MS portfolio • Source: Alamy

More from Value Added Medicines

More from Products